SHOULDER INNOVATIONS, INC. (SI) ROE
- 2026-06-30: ROE -28.18%.
- 2026-03-31: ROE -33.14%.
- 2025-12-31: ROE -28.67%.
- 2025-09-30: ROE -24.61%.
Complete source-backed roe history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -28.18% |
| 2026-03-31 | -33.14% |
| 2025-12-31 | -28.67% |
| 2025-09-30 | -24.61% |
| 2025-06-30 | 40.54% |
| 2025-03-31 | 28.12% |
| 2024-12-31 | 28.56% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -28.67% |
| 2024-12-31 | 28.56% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |